Abbott Laboratories
Nessun attività
Nessun attività
Titoli di debito societari
Di seguito è riportato l'elenco delle obbligazioni Abbott Laboratories, ordinate in base al rendimento minimo garantito. Gli investitori spesso optano per le obbligazioni societarie per la loro maggiore stabilità in periodi di volatilità dei mercati. Studia i prezzi, i rendimenti e altre statistiche e trova un investimento affidabile.
Simbolo | YTW % | Prezzo % | Cedola % | Data di maturazione | Importo in eccesso | Valore nominale | Rating S&P | Rating Fitch | Rating di Moody’s | Emittente |
|---|---|---|---|---|---|---|---|---|---|---|
| AABT3985539St. Jude Medical, LLC 4.75% 15-APR-2043 | 6,98% | 78,25% | 4,750% | 2043-04-15 | 60,87 M USD | 1.000,00 USD | NR | — | — | St. Jude Medical LLC |
 ABT6321053Abbott Laboratories 5.6% 15-MAR-2066 | 6,43% | 88,10% | 5,600% | 2066-03-15 | 2 B USD | 1.000,00 USD | A+ | — | Aa3 | Abbott Laboratories |
| ABT6321054Abbott Laboratories 5.5% 15-MAR-2056 | 6,33% | 88,95% | 5,500% | 2056-03-15 | 3,75 B USD | 1.000,00 USD | A+ | — | Aa3 | Abbott Laboratories |
| US2824BH2Abbott Laboratories 4.9% 30-NOV-2046 | 6,32% | 83,92% | 4,900% | 2046-11-30 | 3,25 B USD | 1.000,00 USD | A+ | — | Aa3 | Abbott Laboratories |
| ABT4466215Abbott Laboratories 4.75% 15-APR-2043 | 6,22% | 84,93% | 4,750% | 2043-04-15 | 639,07 M USD | 1.000,00 USD | A+ | — | Aa3 | Abbott Laboratories |
| ABT.HBAbbott Laboratories 5.3% 27-MAY-2040 | 5,99% | 93,56% | 5,300% | 2040-05-27 | 694,31 M USD | 1.000,00 USD | A+ | — | Aa3 | Abbott Laboratories |
| ABT.GXAbbott Laboratories 6.0% 01-APR-2039 | 5,92% | 100,67% | 6,000% | 2039-04-01 | 514,96 M USD | 1.000,00 USD | A+ | — | Aa3 | Abbott Laboratories |
| ABLCAbbott Laboratories 4.75% 30-NOV-2036 | 5,89% | 91,33% | 4,750% | 2036-11-30 | 1,65 B USD | 1.000,00 USD | A+ | — | Aa3 | Abbott Laboratories |
| ABT.GWAbbott Laboratories 6.15% 30-NOV-2037 | 5,89% | 102,05% | 6,150% | 2037-11-30 | 546,91 M USD | 1.000,00 USD | A+ | — | Aa3 | Abbott Laboratories |
| ABT6321055Abbott Laboratories 4.75% 15-MAR-2038 | 5,88% | 89,65% | 4,750% | 2038-03-15 | 2 B USD | 1.000,00 USD | A+ | — | Aa3 | Abbott Laboratories |
| ABT6321056Abbott Laboratories 4.65% 15-MAR-2036 | 5,88% | 91,17% | 4,650% | 2036-03-15 | 3,75 B USD | 1.000,00 USD | A+ | — | Aa3 | Abbott Laboratories |
| ABT6321057Abbott Laboratories 4.3% 15-MAR-2033 | 5,65% | 92,77% | 4,300% | 2033-03-15 | 2,75 B USD | 1.000,00 USD | A+ | — | Aa3 | Abbott Laboratories |
| ABT6321058Abbott Laboratories 4.0% 15-MAR-2031 | 5,46% | 94,19% | 4,000% | 2031-03-15 | 2,5 B USD | 1.000,00 USD | A+ | — | Aa3 | Abbott Laboratories |
| ABT6321060Abbott Laboratories 3.7% 09-MAR-2029 | 5,24% | 96,57% | 3,700% | 2029-03-09 | 2,25 B USD | 1.000,00 USD | A+ | — | Aa3 | Abbott Laboratories |
| ABT5005072Abbott Laboratories 1.4% 30-JUN-2030 | 5,00% | 87,85% | 1,400% | 2030-06-30 | 650 M USD | 1.000,00 USD | A+ | — | Aa3 | Abbott Laboratories |
| ABT5005071Abbott Laboratories 1.15% 30-JAN-2028 | 4,91% | 95,23% | 1,150% | 2028-01-30 | 650 M USD | 1.000,00 USD | A+ | — | Aa3 | Abbott Laboratories |
| US2824BF6Abbott Laboratories 3.75% 30-NOV-2026 | 4,33% | 99,91% | 3,750% | 2026-11-30 | 1,7 B USD | 1.000,00 USD | A+ | — | Aa3 | Abbott Laboratories |
| XXS207615510Abbott Ireland Financing DAC 0.375% 19-NOV-2027 | 3,37% | 96,75% | 0,375% | 2027-11-19 | 590 M EUR | 1.000,00 EUR | A+ | — | — | Abbott Ireland Financing DAC |
| ABT6321059Abbott Laboratories FRN 09-MAR-2029 | — | 100,19% | 4,258% | 2029-03-09 | 1 B USD | 1.000,00 USD | A+ | — | Aa3 | Abbott Laboratories |